MTOR and kaposiform hemangioendothelioma: The deletion of mTOR (mammalian target of rapamycin)-related proteins tuberous sclerosis complex 2 and phosphatase and tensin homologue would lead to abnormal activation of the mTOR signaling pathway and may involve the pathogenesis of KHE, suggesting sirolimus as a good therapeutic choice [30].